Log In
Print this Print this

Duexis, ibuprofen/famotidine (HZT-501)

Also known as: Duexa

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionFixed-dose combination of 800 mg ibuprofen and 26.6 mg famotidine, a histamine H2 receptor (HRH2; H2R) antagonist
Molecular Target Histamine H2 receptor (HRH2) (H2R)
Mechanism of ActionHistamine H2 receptor antagonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today